Researcher
Johan Michiels
Publications
11 - 20 of 50
- Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): a single blind, randomized, non-inferiority trial(2022)
Authors: Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, L Heyndrickx, J Michiels, B Willems, Stéphane De Craeye, Antoine Francotte, et al.
Pages: e0001308 - Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant(2022)
Authors: Kevin Ariën, L Heyndrickx, J Michiels, K Vereecken, Kurt Van Lent, S Coppens, B Willems, Pieter Pannus, Geert A Martens, Marjan Van Esbroeck, et al.
- A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell mediated immunity(2022)
Authors: Sean McCafferty, Akm Ashiqul Haque, Aster Vandierendonck, Brian Weidensee, Magalie Plovyt, Magdalena Stuchlíková, Nathalie François, Sophie Valembois, L Heyndrickx, J Michiels, et al.
Pages: 2968-2983 - Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium(2022)
Authors: Irith De Baetselier, C Kenyon, Jasmine Coppens, J Michiels, Tessa de Block, H. Smet, S Coppens, Fien Vanroye, Joachim Jakob Bugert, Philipp Girl, et al.
Pages: 2288-2292 - Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay(2021)
Authors: Joachim Mariën, Ann Ceulemans, J Michiels, L Heyndrickx, Karen Kerkhof, N. Foque, Marc-Alain Widdowson, Laure Mortgat, Els Duysburgh, Isabelle Desombere, et al.
- Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes(2021)
Authors: Pieter Pannus, Kristof Y. Neven, Stephane De Craeye, L Heyndrickx, Sara Vande Kerckhove, Daphnée Georges, J Michiels, Antoine Francotte, Marc Van Den Bulcke, Maan Zrein, et al.
Pages: e695–e704 - A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity(2021)
Authors: Annemieke Smet, Tom Breugelmans, J Michiels, Kevin Lamote, Wout Arras, Joris G De Man, L Heyndrickx, Anne Hauner, Manon Huizing, Surbhi Malhotra-Kumar, et al.
- Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients(2021)
Authors: Lorenzo Canti, Stephanie Humblet-Baron, Isabelle Desombere, Julika Neumann, Pieter Pannus, L Heyndrickx, Aurelie Henry, Sophie Servais, Evelyne Willems, Gregory Ehx, et al.
- Dynamics of the magnitude, breadth and depth of the antibody response at epitope level following dengue infection(2021)
Authors: Francesca Falconi Agapito, Karen Kerkhof, Xiomara Merino, J Michiels, Marjan Van Esbroeck, Koen Bartholomeeusen, Michael Talledo, Kevin Ariën
- Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2(2021)
Authors: Joachim Mariën, J Michiels, L Heyndrickx, Antoine Nkuba-Ndaye, Ann Ceulemans, Koen Bartholomeeusen, Joule Madinga, Placide Mbala-Kingebeni, Veerle Vanlerberghe, Steve Ahuka-Mundeke, et al.